SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending with significant investor speculation around its newly operational Eagle Line pilot production facility, which hints at advanced solid-state battery scalability and potential OEM partnerships. While long-term bulls see this as a pivotal step towards future licensing revenue, many in the community remain critical of the continued pre-revenue status, ongoing cash burn, and lack of concrete commercialization timelines.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending amid a severe sector-wide sell-off, with widespread fears that advanced AI tools will disrupt or replace traditional enterprise software. However, many in the community and market analysts view this as an irrational overreaction, highlighting Salesforce's strong fundamentals, AI integration, and current undervaluation as a significant buying opportunity.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is trending after reporting strong Q4 earnings, which beat revenue and EPS estimates and highlighted robust growth, despite the stock seeing a perplexing post-earnings sell-off. The community is actively debating this market reaction, largely attributing it to algorithmic trading and manipulation while emphasizing the company's solid AI-powered ad-tech fundamentals.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community eagerly discusses its oral obesity drug, VK2735, advancing directly to Phase 3 trials, accelerating its pipeline and strengthening its competitive position in the lucrative GLP-1 market.

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

NovoCure is trending following FDA approval of its Optune Pax for locally advanced pancreatic cancer, a significant milestone for this aggressive disease, with community sentiment split between high optimism for its breakthrough potential and skepticism recalling past volatility and commercialization hurdles.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to a dual narrative: the successful unfolding of its massive BlueBird 6 satellite and inclusion in the MSCI Index signal technical validation and institutional interest, while a proposed $1 billion convertible notes offering sparks intense debate over potential dilution versus necessary funding for future growth in AI and government space projects.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is seeing significant discussion following its robust Q4 2025 earnings, which revealed record revenue, gross margin, and its first profitable fiscal year, with the CEO highlighting AI as an increasing tailwind for its edge platform. Long-term investors are celebrating this financial inflection point as a potential turnaround, though some in the community remain wary of the rally's sustainability.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X is trending due to its imminent merger to become Infleqtion (INFQ) on the NYSE, with the community buzzing over its recent NASA space mission and U.S. Department of Energy contracts. Investors are actively debating its significant undervaluation and leadership in quantum technology compared to industry peers, expecting substantial post-merger growth.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco (CSCO) is rallying sharply after beating earnings expectations and raising its full-year guidance, driven by accelerating AI infrastructure orders from hyperscalers. While initial concerns over gross margin forecasts caused some volatility, the market is now enthusiastically pushing the stock toward its dot-com era highs, with the community actively discussing its role as a key beneficiary in the AI buildout.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software Inc. ($U) is seeing a significant sell-off after reporting a Q4 earnings beat but issuing weaker-than-expected Q1 guidance, fueling concerns about AI competition like Google's Project Genie. The community is actively debating if the drastic dip is an overreaction and a "buy the dip" opportunity, citing underlying business strengths like Vector ads and new AI tool developments, or if current market pressures will persist amid acquisition rumors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Recommendation of "Hold" from Brokerages

Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven ratings firms that are covering the firm, MarketBeat.com reports. One...

Astria Stockholders Vote to Approve Acquisition by BioCryst

Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astrias stockholders held on January 21, 2026, Astrias stockholders voted to approve the acquisition of Astria...

Short Interest in Astria Therapeutics, Inc. (NASDAQ:ATXS) Increases By 37.9%

Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totaling 5,752,164 shares, a growth of...

Astria Therapeutics (NASDAQ:ATXS) Share Price Crosses Below Fifty Day Moving Average - Here's What Happened

Astria Therapeutics (NASDAQ:ATXS) Shares Pass Below Fifty Day Moving Average - Should You Sell...

BioCryst Pharmaceuticals Touts ORLADEYO Momentum, Astria Deal and 2026 Outlook at JPM Conference

BioCryst Pharmaceuticals (NASDAQ:BCRX) outlined a multi-pronged growth strategy at the JPMorgan Healthcare Conference, highlighting continued momentum for its hereditary angioedema (HAE) franchise, a...

Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to...

Astria Therapeutics, Inc. (NASDAQ:ATXS) Given Average Recommendation of "Hold" by Brokerages

Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) has been given a consensus recommendation of "Hold" by the eleven brokerages that are presently covering the stock, MarketBeat Ratings...

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS, MBCN, FMNB, and SEMR $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ATXS...

Astria Therapeutics, Inc. $ATXS Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) by 4,607.1% during the second quarter, according to its most recent 13F filing with the Securities...

Panagora Asset Management Inc. Purchases New Holdings in Astria Therapeutics, Inc. $ATXS

Panagora Asset Management Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.

Astria Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

ATXS
Astria Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ATXS News

ATXSAstria Therapeutics Inc